We develop innovative solutions based on the analysis of exhaled bio-markers, using them as tools to diagnose, predict and monitor a wide range of respiratory diseases, such as asthma. We are currently using the evernoa device, which allows us to measure the inflammation level of an airway by detecting nitric oxide through a simple, non-invasive test.
Navarra Startups
